Traveler's diarrhea

Revision as of 21:35, 6 January 2015 by Rossdonaldson1 (talk | contribs)

Background

  • Most respond to antibiotics
  • as duration of diarrhea increases, higher chance of parasitic cause
  • Most cases of traveler’s diarrhea are caused by bacterial enteropathogens, whereas bacterial pathogens cause less than 15% of endemic diarrhea cases in adults living in their home country[1]

Etiology

Organism Latin America and Caribbean Africa South Asia Southeast Asia
Enterotoxigenic Escherichia coli ≥35 25-35 15-25 5-15
Enteroaggregative E coli 25-35 <5 15-25 No data
Campylobacter <5 <5 15-25 25-35
Salmonella <5 5-15 <5 5-15
Shigella 5-15 5-15 5-15 <5
Norovirus 15-25 15-25 5-15 <5
Rotavirus 15-25 5-15 5-15 <5
Giardia <5 <5 5-15 5-15

Differential Diagnosis

Acute diarrhea

Infectious

Noninfectious

Watery Diarrhea

Traveler's Diarrhea


Diagnosis[3]

  • Travel
  • 3 or more unformed stools per 24 hours
  • plus (at least 1 of the following):
    • abdominal cramps
    • tenesmus
    • nausea
    • vomiting
    • fever
    • fecal urgency
The average duration of untreated traveler’s diarrhea is 4 to 5 days

Workup

Uncomplicated Diarrhea

  • No workup

Fever, Bloody Stools, or Ill Appearing

  • Stool culture
  • Systemic toxicity
    • Extended workup including blood cultures

Persistent or Refractory Diarrhea (>14 days)

Treatment

  • Consider ondansteron if nausea
  • Consider IVF if dehydrated
  • Consider loperamide 4mg PO after each loose stool (Max: 16mg/day)
    • if very frequent stools and no contra-indication:
      • Not pregnant
      • >2 years old
      • fever or bloody stools without concomitant antibiotics (don't use as sole therapy)

Antibiotics

  • Ciprofloxacin 750mg PO once daily x 1-3 days[4]
    • First choice for use except in South and Southeast Asia[5]
  • Azithromycin 500mg PO q24h x 3 days OR 1000mg PO x 1[6]
    • Nausea is a frequent adverse event[7]
    • First choice for use in South and Southeast Asia[8]
  • Rifaximin 200mg PO TID x 3 days[9]

Pediatrics

Antibiotic Options:

Avoid fluroquinolones

Disposition

  • Outpatient, for the vast majority
  • If systemic toxicity, consider admission

Complications

  • Postinfectious irritable bowel syndrome
    • Occurs in 3-17% of patients
    • Risk factors
      • Severity of traveler’s diarrhea
      • Number of episodes
      • Pretravel diarrhea
      • Pretravel adverse life events
      • Infection with heat-labile toxin–producing ETEC
  • Reactive arthritis
  • Guillain-Barré syndrome


See Also

Source

  1. Steffen R, et al. Traveler’s Diarrhea: A Clinical Review. JAMA. 2015;313(1):71-80. doi:10.1001/jama.2014.17006
  2. Marx et al. “Cholera and Gastroenteritis caused by Noncholera Vibrio Species”. Rosen’s Emergency Medicine 8th edition vol 1 pg 1245-1246.
  3. Steffen R, et al. Traveler’s Diarrhea: A Clinical Review. JAMA. 2015;313(1):71-80. doi:10.1001/jama.2014.17006
  4. Hoge CW. et al. Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years. Clin Infect Dis. 1998;26:341–5
  5. Steffen R, et al. Traveler’s Diarrhea: A Clinical Review. JAMA. 2015;313(1):71-80. doi:10.1001/jama.2014.17006
  6. Sanders JW. et al. An observational clinic-based study of diarrheal illness in deployed United States military personnel in Thailand: presentation and outcome of Campylobacter infection. Am J Trop Med Hyg. 2002;67:533–8
  7. Steffen R, et al. Traveler’s Diarrhea: A Clinical Review. JAMA. 2015;313(1):71-80. doi:10.1001/jama.2014.17006
  8. Steffen R, et al. Traveler’s Diarrhea: A Clinical Review. JAMA. 2015;313(1):71-80. doi:10.1001/jama.2014.17006
  9. DuPont HL. et al. Rifaximin versus ciprofloxacin for the treatment of traveler’s diarrhea: a randomized, double-blind clinical trial. Clin Infect Dis. 2001;33:1807–15
  10. Stauffer WM, Konop RJ, Kamat D. Traveling with infants and young children. Part III: travelers’ diarrhea. J Travel Med. 2002;9:141–50